IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides

被引:185
作者
Niwa, R [1 ]
Natsume, A [1 ]
Uehara, A [1 ]
Wakitani, M [1 ]
Iida, S [1 ]
Uchida, K [1 ]
Satoh, M [1 ]
Shitara, K [1 ]
机构
[1] Kyowa Hakko Kogyo Co Ltd, Pharmaceut Res Ctr, Dept Antibody Res, Tokyo 1948533, Japan
关键词
antibody oligosaccharide; antibody-dependent cellular cytotoxicity; IgG; fucose;
D O I
10.1016/j.jim.2005.08.009
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Fucose depletion from oligosaccharides of human IgG 1-type antibodies results in a great enhancement of antibody-dependent cellular cytotoxicity (ADCC). The aim of this study was to clarify the effect of fucose removal on effector functions of all human IgG subclasses. A panel of anti-CD20 chimeric antibodies having a matched set of human heavy chain subclasses with different fucose contents in their oligosaccharides was constructed using wild-type and fucosyltransferase-knockout Chinese hamster ovary cells as host cells. As found previously for IgG 1, fucose-negative variant of IgG2, IgG3, and IgG4 exhibited enhanced ADCC and Fc gamma RIIIa binding compared with their highly fucosylated counterparts. In contrast, facose removal did not affect complement-dependent cytotoxicity (CDC) of any IgGs. Consequently, fucose removal from IgG2 and IgG4 resulted in a unique effector function profile; they had potent ADCC and no CDC. In conclusion fucose depletion can provide a panel of IgGs with enhanced ADCC without an impact on other inherent properties specific for each IgG subclass, such as CDC. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 160
页数:10
相关论文
共 35 条
  • [1] A SINGLE AMINO-ACID SUBSTITUTION ABOLISHES THE HETEROGENEITY OF CHIMERIC MOUSE/HUMAN (IGG4) ANTIBODY
    ANGAL, S
    KING, DJ
    BODMER, MW
    TURNER, A
    LAWSON, ADG
    ROBERTS, G
    PEDLEY, B
    ADAIR, JR
    [J]. MOLECULAR IMMUNOLOGY, 1993, 30 (01) : 105 - 108
  • [2] The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus
    Anolik, JH
    Campbell, D
    Felgar, RE
    Young, F
    Sanz, I
    Rosenblatt, J
    Looney, RJ
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (02): : 455 - 459
  • [3] The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H
    Boyd, PN
    Lines, AC
    Patel, AK
    [J]. MOLECULAR IMMUNOLOGY, 1995, 32 (17-18) : 1311 - 1318
  • [4] Improving the efficacy of antibody-based cancer therapies
    Carter, P
    [J]. NATURE REVIEWS CANCER, 2001, 1 (02) : 118 - 129
  • [5] Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
    Cartron, G
    Dacheux, L
    Salles, G
    Solal-Celigny, P
    Bardos, P
    Colombat, P
    Watier, H
    [J]. BLOOD, 2002, 99 (03) : 754 - 758
  • [6] Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
    Clynes, RA
    Towers, TL
    Presta, LG
    Ravetch, JV
    [J]. NATURE MEDICINE, 2000, 6 (04) : 443 - 446
  • [7] Cole MS, 1997, J IMMUNOL, V159, P3613
  • [8] Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc
    Idusogie, EE
    Presta, LG
    Gazzano-Santoro, H
    Totpal, K
    Wong, PY
    Ultsch, M
    Meng, YG
    Mulkerrin, MG
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (08) : 4178 - 4184
  • [9] A COMPARATIVE-STUDY OF THE N-LINKED OLIGOSACCHARIDE STRUCTURES OF HUMAN-IGG SUBCLASS PROTEINS
    JEFFERIS, R
    LUND, J
    MIZUTANI, H
    NAKAGAWA, H
    KAWAZOE, Y
    ARATA, Y
    TAKAHASHI, N
    [J]. BIOCHEMICAL JOURNAL, 1990, 268 (03) : 529 - 537
  • [10] Fc gamma RIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gamma RIIIa, independently of the Fc gamma IIIa-48L/R/H phenotype
    Koene, HR
    Kleijer, M
    Algra, J
    Roos, D
    vondemBorne, AEGK
    deHaas, M
    [J]. BLOOD, 1997, 90 (03) : 1109 - 1114